FORE US Bio

FORE US Bio is a startup headquartered in Philadelphia, United States, founded in 2022. It has raised at least $37.4m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated 7 October 2026.

Funding

FORE US Bio has raised at least $37.4m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

FORE US Bio sits inside the Philadelphia region R&D ecosystem in the Global R&D Labs Directory.

Other startups in Philadelphia

• Alveus Therapeutics
• BlueWhale Bio
• Daymark Health
• Interius BioTherapeutics
• Metabolics Pharma
• OnCall Health
• Peptaris
• QualiaOS
• Ritten
• Tolerance Bio
• Twenty30 Health

Related

• Innovation profile of Philadelphia
• United States: economy and key statistics
• Global Investors Directory
• All 311 Indexes

Questions and answers

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.